rfk jr glp-1 Jr. on coverage for medication, HHS cuts rfk glp 1 robert f

Pendulum GLP-1 Probiotic Pro is a next-generation probiotic designed to support the gutbrainmetabolism axis and promote balanced metabolic wellness

Women in menopause are turning to GLP1 weight-loss drugs

Weight loss is known to trigger compensatory biology: Increased appetite signaling Reduced resting energy expenditure Heightened food reward sensitivity Stopping GLP-1 therapy at peak dose, without tapering and without reinforcing lifestyle strategies at the exact moment hunger returns, does not allow lifestyle behaviors to take over. Emerging real-world data and obesity physiology suggest a different, more clinically relevant path: Gradual dose reduction rather than abrupt cessation Continued, structured dietary and exercise support Active monitoring during the high-risk post-cessation period We still need randomized trials designed specifically to test tapering and lifestyle-anchored maintenance strategies

Request solution details today!

Beyond their roles in diabetes treatment, AGIs have shown potential in extending lifespan and effectively treating aging-related diseases by modulating oxidative stress, gut microbiota, inflammatory responses, and nutrient-sensing pathways

The GLP-1 receptor agonist drug class has revolutionized obesity treatment, but key unmet needs persist